Nephrotic syndrome due to membranous nephropathy associated with metastatic prostate cancer: Rapid remission after initial endocrine therapy
Citation
H. Matsuura et al., Nephrotic syndrome due to membranous nephropathy associated with metastatic prostate cancer: Rapid remission after initial endocrine therapy, NEPHRON, 84(1), 2000, pp. 75-78
Categorie Soggetti
Urology & Nephrology","da verificare
SICI code
0028-2766(200001)84:1<75:NSDTMN>2.0.ZU;2-I
Abstract
A case of severe nephrotic syndrome (urinary protein excretion 12.9 g/day)
due to membranous nephropathy associated with untreated prostate cancer and
multiple bone metastases is described. A combination of initial endocrine
treatment and steroid therapy resulted in normalization of prostate-specifi
c antigen levels followed by a rapid decrease of urinary protein excretion
within 4 months, No proteinuria was subsequently detected. Seven months aft
er the initiation of therapy, the patient remained well with complete clini
cal remission from the nephrotic syndrome; This rapid achievement of remiss
ion may have been due to tumor shrinkage by androgen ablation in addition t
o steroid therapy of the membranous nephropathy. The nephrotic syndrome is
a rare complication of pi-estate cancer, and, to the best of our knowledge,
no previous cases have been reported of membranous nephropathy as one of t
he first disease manifestations. Copyright (C) 2000 S. Karger AG, Basel.